These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3534102)

  • 1. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes.
    Kupper TS; McGuire J
    J Invest Dermatol; 1986 Nov; 87(5):570-3. PubMed ID: 3534102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of in vitro and in vivo UV irradiation on the production of ETAF activity by human and murine keratinocytes.
    Ansel JC; Luger TA; Green I
    J Invest Dermatol; 1983 Dec; 81(6):519-23. PubMed ID: 6196420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ultraviolet radiation on production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro.
    Gahring L; Baltz M; Pepys MB; Daynes R
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1198-202. PubMed ID: 6608106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultraviolet radiation inhibits alloantigen presentation by epidermal cells: partial reversal by the soluble epidermal cell product, epidermal cell-derived thymocyte-activating factor (ETAF).
    Sauder DN; Noonan FP; DeFabo EC; Katz SI
    J Invest Dermatol; 1983 Jun; 80(6):485-9. PubMed ID: 6222123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging.
    Sauder DN; Stanulis-Praeger BM; Gilchrest BA
    Arch Dermatol Res; 1988; 280(2):71-6. PubMed ID: 3260767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance.
    Gahring LC; Daynes RA
    J Immunol; 1986 Apr; 136(8):2868-74. PubMed ID: 2420872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of an epidermal cell thymocyte-activating factor (ETAF) produced by human epidermal cells and a human squamous cell carcinoma cell line.
    Luger TA; Stadler BM; Luger BM; Sztein MB; Schmidt JA; Hawley-Nelson P; Grabner G; Oppenheim JJ
    J Invest Dermatol; 1983 Sep; 81(3):187-93. PubMed ID: 6604110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
    Pignol B; Lonchampt MO; Chabrier PE; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S83-91. PubMed ID: 2133287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immunoregulatory cytokines produced by epidermal cells.
    Luger TA; Köck A; Danner M
    Scand J Immunol; 1985 May; 21(5):455-62. PubMed ID: 3890150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of murine and human epidermal cell-derived thymocyte-activating factor.
    Luger TA; Sztein MB; Schmidt JA; Murphy P; Grabner G; Oppenheim JJ
    Fed Proc; 1983 Jul; 42(10):2772-6. PubMed ID: 6602721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinocytes from normal and uninvolved psoriatic skin.
    Kragballe K; Marcelo CL; Voorhees JJ; Sauder DN
    J Invest Dermatol; 1987 Jan; 88(1):8-10. PubMed ID: 3491857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte membrane-associated epidermal cell-derived thymocyte-activating factor (ETAF).
    Goldminz D; Kupper TS; McGuire J
    J Invest Dermatol; 1987 Jan; 88(1):97-100. PubMed ID: 2947956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin 1.
    Luger TA; Stadler BM; Luger BM; Mathieson BJ; Mage M; Schmidt JA; Oppenheim JJ
    J Immunol; 1982 May; 128(5):2147-52. PubMed ID: 6801132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidocaine-induced inhibition of the production of interleukin 1-like epidermal cell-derived thymocyte activating factor.
    Enk C
    J Invest Dermatol; 1989 Aug; 93(2):268-71. PubMed ID: 2787824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
    Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
    J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic properties of epidermal cell thymocyte-activating factor (ETAF).
    Sauder DN
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):176s-179s. PubMed ID: 3874245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.
    Luger TA; Uchida A; Köck A; Colot M; Micksche M
    J Immunol; 1985 Apr; 134(4):2477-83. PubMed ID: 3882831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation.
    Kupper TS; Chua AO; Flood P; McGuire J; Gubler U
    J Clin Invest; 1987 Aug; 80(2):430-6. PubMed ID: 3497177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal cell-derived thymocyte activating factor (ETAF) is a potent T-cell chemoattractant.
    Sauder DN; Monick MM; Hunninghake GW
    J Invest Dermatol; 1985 Nov; 85(5):431-3. PubMed ID: 2414368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulation using an epidermal cytokine (ETAF)].
    Luger TA; Niebauer G
    Z Hautkr; 1984 Jan; 59(1):18, 23-34. PubMed ID: 6367244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.